Johnson & Johnson: Ischemic Stroke trials

The registry lists 10 Ischemic Stroke studies with Johnson & Johnson as lead sponsor. 2 are open to participants now and 4 have results posted.

Phase 3 2No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study to Monitor Safety and Effectiveness of Approved J&J MedTech Devices in the Treatment of Participants With Ischemic StrokeNot yet recruitingNCT07760649
• A Pivotal Study Evaluating Safety and Effectiveness of Adaptative Tip Catheter in Patients With Acute Ischemic StrokeRecruitingNCT07367100Not applicable
• Prospective Evaluation to Characterize the Real-World Performance of the EMBOVAC Aspiration CatheterCompletedNCT04531904Results posted
• Analysis of Revascularization in Ischemic Stroke With EmboTrapCompletedNCT02488915Not applicableResults posted
• Analysis of Revascularisation in Ischemic Stroke With EmboTrapTerminatedNCT02190552Results posted
• Reperfuse Ischemic Vessels With Endovascular Recanalization Device in JAPAN (RIVER JAPAN)CompletedNCT01895634Not applicableResults posted
• Safety, Performance of CEREGLIDE 92 Intermediate Catheter in Treatment of Acute Ischemic StrokeWithdrawnNCT06386289Not applicable
• A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKEActive, not recruitingNCT05702034Phase 3
• Relative Risks for Non-fatal Venous Thromboembolism, Ischemic Stroke and Myocardial Infarction in Users of ORTHO EVRA(Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared to Levonorgestrel-containing Oral Contraceptives.CompletedNCT00511784
• A Study of Effectiveness and Safety of Abciximab in Patients With Acute Ischemic Stroke (AbESTT-II)TerminatedNCT00073372Phase 3